Kaushik J Dave's Net Worth
$1.03 Million
Who is Kaushik J Dave?
Kaushik J Dave has an estimated net worth of $1.03 Million. This is based on reported shares across multiple companies, which include ANTARES PHARMA, INC., and Actinium Pharmaceuticals, Inc..
SEC CIK
Kaushik J Dave's CIK is 0001522751
Past Insider Trading and Trends
2013 was Kaushik J Dave's most active year for acquiring shares with 6 total transactions. Kaushik J Dave's most active month to acquire stocks was the month of April. 2015 was Kaushik J Dave's most active year for disposing of shares, totalling 6 transactions. Kaushik J Dave's most active month to dispose stocks was the month of April. 2013 saw Kaushik J Dave paying a total of $4,550,700.00 for 846,005 shares, this is the most they've acquired in one year. In 2013 Kaushik J Dave cashed out on 120,000 shares for a total of $240,788.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ANTARES PHARMA, INC. No price found
Executive Vice PresidentKaushik J Dave owns 265,028 units of Common Stock. From 2011 to 2013 Kaushik J Dave acquired a total of 191,091 shares in ANTARES PHARMA, INC. at a cost of $28,200.00, Kaushik also disposed a total of 60,000 shares of ANTARES PHARMA, INC. equalling to $240,788.40.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.24 | -$169,987.20 | 265.03K |
Scheduled
|
Jun 3
| ||
Form 4
| +28.59% | 58.92K |
—
|
—
| 265.03K |
May 22
| |||
Form 4
|
—
|
0
|
$2.25 | -$42,601.20 | 206.11K |
Scheduled
|
May 6
| ||
Form 4
| +10.97% | 21.13K |
—
|
—
| 213.72K |
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +9.61% | 16.89K |
—
|
—
| 192.59K |
Feb 10
| |||
Form 4
| +24.13% | 34.16K |
—
|
—
| 175.71K |
Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Actinium Pharmaceuticals, Inc. (ATNM) Snapshot price: $5.1
CEO and Interim CFOKaushik J Dave owns 88,500 units of Common stock which is worth $451,350.00. From 2013 to 2017 Kaushik J Dave acquired a total of 10,000 shares in Actinium Pharmaceuticals, Inc. at a cost of $20,180.00, Kaushik also disposed a total of 156,084 shares of Actinium Pharmaceuticals, Inc. equalling to $382,405.80.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
| +12.74% | 10K |
$2.02 | $20,180.00 | 88.5K |
Apr 14 - Apr 15
| |||
Form 4
| -38.98% | -156.08K |
$2.45 | -$382,405.80 | 301.33K |
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||